IMMY17015 / Cellectar / Brea Lipe
Research Question:
Is the study drug, CLR 131, effective for the treatment of multiple myeloma or certain
lymphomas?
Basic Study Information
Purpose:
This study evaluates CLR 131 in patients with select B-cell malignancies (multiple
myeloma( MM), indolent chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma
(SLL), lymphoplasmacytic lymphoma (LPL), marginal zone lymphoma (MZL), mantle cell
lymphoma (MCL), and diffuse large B-cell lymphoma (DLBCL) who have been previously
treated with standard therapy for their underlying malignancy.
Location: Cancer Center
Study Web URL: https://clinicaltrials.gov/ct2/show/NCT02952508?term=02952508&rank=1
Study Reference #: IMMY17015
Lead Researcher (Principal Investigator)
Lead Researcher:
Brea Lipe
Study Contact Information
Study Coordinator: Tina Bowdish
Phone: +1 585-275-9475
Email: tina_bowdish@urmc.rochester.edu
Additional Study Details
Learn More About These Conditions
More information about Lymphoma
More information about Multiple Myeloma
Trial Not Found
The study you are looking for is not active at this time.
Return to Search